Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 19, 2014

Drug Name	Review Type	Class	Manufacturer
Sovaldi	New Drug Initial Review	Hepatitis C	Gilead
Otrexup	New Drug Initial Review	DMARD	Antares
Brintellix	New Drug Initial Review	Antidepressant	Takeda
Olysio	New Drug Initial Review	Hepatitis C	Johnson & Johnson
Natroba	New Drug Appeal	Head Lice	ParaPro
Quillivant XR	New Drug Appeal	Stimulant/ADHD	Pfizer
Linzess	New Drug Appeal	Guanylate Cyclase-C Agonist	Forest
TOBI Podhaler	New Drug Appeal	Aminoglycoside	Novartis
Abilify Maintena	PDL Appeal	Atypical Antipsychotic	Otsuka
Onglyza	PDL Appeal	DPP-4 Inhibitor	AstraZeneca

Footer